ArticleClinical and experimental immunology2023

MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.

Sonia Elhadad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.